Skye Bioscience Inc (SKYE)

[Investor Jesus]

Anton is back! Where's Vinpat?

Been following NMUS since its debut. Largely unimpressed thus far.

Seemingly it is old news. There's also another occasion where NMUS entered a similar agreement with AMRI with the same drug - so three times they've done this with AMRI. My guess is that they brought the drug (NB1111) to the FDA and were rejected... twice.

Viewing the old presentation from February 2016, the first time they entered an agreement AMRI, they were developing THC-VHS SLN. The presentation cites novelties of the drug: neuroprotective, IOP data, and lack of side effects.

The presentation from June of this year presents the same THC-VHS SLN, the same data, and cites the same novelties. It seems like they're going to the FDA with the same case for NB1111. Why should we expect a different response? They've done very little to explain their case here and why this time around we'll see the FDA give the go ahead.

NMUS has been historically poor at communicating with investors. It's frustrating to see them cite lack of capital for their inability to advance their pipeline yet their board members collect six-figure incomes and the shares are diluted for their benefits packages.

I'll be surprised to see this advance to Phase I. I think Dr. Murphy and his pals are happy to sit around, not actually do anything, and collect their benefits.